JPS60202812A - ブロモクリプチン組成物 - Google Patents

ブロモクリプチン組成物

Info

Publication number
JPS60202812A
JPS60202812A JP60040277A JP4027785A JPS60202812A JP S60202812 A JPS60202812 A JP S60202812A JP 60040277 A JP60040277 A JP 60040277A JP 4027785 A JP4027785 A JP 4027785A JP S60202812 A JPS60202812 A JP S60202812A
Authority
JP
Japan
Prior art keywords
bromocriptine
formulation according
substance
preparation according
fatty material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60040277A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0448776B2 (da
Inventor
オトマー・ツユーガー
ノルマン・マツエール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS60202812A publication Critical patent/JPS60202812A/ja
Publication of JPH0448776B2 publication Critical patent/JPH0448776B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP60040277A 1984-02-29 1985-02-27 ブロモクリプチン組成物 Granted JPS60202812A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB8405227 1984-02-29

Publications (2)

Publication Number Publication Date
JPS60202812A true JPS60202812A (ja) 1985-10-14
JPH0448776B2 JPH0448776B2 (da) 1992-08-07

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60040277A Granted JPS60202812A (ja) 1984-02-29 1985-02-27 ブロモクリプチン組成物

Country Status (26)

Country Link
JP (1) JPS60202812A (da)
AT (1) AT387716B (da)
AU (2) AU586621B2 (da)
BE (1) BE901810A (da)
CA (1) CA1256374A (da)
CH (2) CH666406A5 (da)
DE (1) DE3505743C2 (da)
DK (1) DK175016B1 (da)
ES (1) ES8705223A1 (da)
FR (1) FR2560047B1 (da)
GB (1) GB8405227D0 (da)
GR (1) GR850506B (da)
HK (1) HK85490A (da)
HU (1) HU196121B (da)
IE (1) IE58235B1 (da)
IL (1) IL74459A (da)
IT (1) IT1199948B (da)
LU (1) LU85791A1 (da)
MX (1) MX9203626A (da)
NL (1) NL194231C (da)
NZ (1) NZ211247A (da)
PH (1) PH23266A (da)
PT (1) PT80015B (da)
SE (2) SE462259B (da)
SG (1) SG69390G (da)
ZA (1) ZA851546B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51115910A (en) * 1975-03-17 1976-10-13 Hoffmann La Roche Gradually releaseetype medical composition and its preparation
JPS57120515A (en) * 1980-11-29 1982-07-27 Sandoz Ag Medicinal composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (da) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51115910A (en) * 1975-03-17 1976-10-13 Hoffmann La Roche Gradually releaseetype medical composition and its preparation
JPS57120515A (en) * 1980-11-29 1982-07-27 Sandoz Ag Medicinal composition

Also Published As

Publication number Publication date
DK86785D0 (da) 1985-02-26
MX9203626A (es) 1992-09-01
PT80015B (pt) 1987-09-18
IL74459A (en) 1988-12-30
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
GB8405227D0 (en) 1984-04-04
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
FR2560047A1 (fr) 1985-08-30
CA1256374A (en) 1989-06-27
PH23266A (en) 1989-06-23
IT1199948B (it) 1989-01-05
NL194231C (nl) 2001-10-02
DK86785A (da) 1985-08-30
SE8500961L (sv) 1985-08-30
HK85490A (en) 1990-10-25
IT8547703A0 (it) 1985-02-20
NL8500417A (nl) 1985-09-16
AU618599B2 (en) 1992-01-02
CH666406A5 (de) 1988-07-29
DK175016B1 (da) 2004-04-26
ZA851546B (en) 1986-10-29
IE58235B1 (en) 1993-08-11
ES8705223A1 (es) 1987-05-01
CH667009A5 (de) 1988-09-15
SE8500961D0 (sv) 1985-02-27
BE901810A (fr) 1985-08-26
AT387716B (de) 1989-03-10
AU3500689A (en) 1989-09-14
HU196121B (en) 1988-10-28
DE3505743A1 (de) 1985-08-29
IL74459A0 (en) 1985-05-31
AU3913685A (en) 1985-09-05
ATA58085A (de) 1988-08-15
HUT38254A (en) 1986-05-28
SE462259B (sv) 1990-05-28
IE850495L (en) 1985-08-29
GR850506B (da) 1985-06-28
JPH0448776B2 (da) 1992-08-07
SG69390G (en) 1990-10-26
DE3505743C2 (de) 1995-02-16
AU586621B2 (en) 1989-07-20
FR2560047B1 (fr) 1988-01-15
NZ211247A (en) 1989-02-24
LU85791A1 (fr) 1985-12-11

Similar Documents

Publication Publication Date Title
EP0218148B1 (en) Slow-release pharmaceutical composition
JP5752227B2 (ja) 口腔内崩壊錠
JPH0122245B2 (da)
JPS5839618A (ja) 持続性積層錠剤
EP2200591A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
PT88099B (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
CA2182004C (en) Film coated tablet of paracetamol and domperidone
JP2004518734A (ja) カルベジロールの新規処方
PT85128B (pt) Processo para a preparacao de composicoes farmaceuticas contendo, como ingrediente activo, 4-(1-metil-4-piperidilideno)-4h-benzo-{4,5}ciclohepta{1,2-b}tiofeno--10(9h)-ona
GB2154874A (en) Bromocriptine compositions
JPS63290818A (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
JP5721093B2 (ja) 崩壊錠
KR920010388B1 (ko) 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 약학제제의 제조방법
JPS60202812A (ja) ブロモクリプチン組成物
JPH0899875A (ja) ゲンフィブロジル含有製剤組成物およびその製造法
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
KR920008817B1 (ko) 조절된 방출성(서방성) 약학적 제제의 제조방법.
HU225779B1 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
IL151205A (en) Solid gleneal forms of molsidomine for oral administration with delayed release
JPH1121233A (ja) マルチプルユニットタイプ徐放性錠剤
JP2002518330A (ja) 処置方法
JPH0466846B2 (da)
PL194595B1 (pl) Preparat tiagabiny o przedłużonym uwalnianiu orazjego zastosowanie
JPH11501026A (ja) イソソルビド−５−モノナイトレートの使用
JPS62149618A (ja) 活性物質放出制御医薬製剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term